BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Broecker-Preuss M, Becher-Boveleth N, Müller S, Mann K. The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells. Cancer Cell Int 2016;16:27. [PMID: 27042160 DOI: 10.1186/s12935-016-0303-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Yu Z, Guo J, Meng T, Ge L, Liu L, Wang H, Yang X. Bcl-xL DNAzymes promote radiosensitivity and chemosensitivity in colorectal cancer cells via enhancing apoptosis. BMC Pharmacol Toxicol 2022;23. [DOI: 10.1186/s40360-022-00553-x] [Reference Citation Analysis]
2 Townsend PA, Kozhevnikova MV, Cexus ONF, Zamyatnin AA Jr, Soond SM. BH3-mimetics: recent developments in cancer therapy. J Exp Clin Cancer Res 2021;40:355. [PMID: 34753495 DOI: 10.1186/s13046-021-02157-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
3 Nguyen W, Lee EF, Evangelista M, Lee M, Harris TJ, Colman PM, Smith NA, Williams LB, Jarman KE, Lowes KN, Haeberli C, Keiser J, Smith BJ, Fairlie WD, Sleebs BE. Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2. ACS Infect Dis 2021;7:1143-63. [PMID: 33523649 DOI: 10.1021/acsinfecdis.0c00700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sharma S, Varsha KK, Ray U, Siddiqua H, Jose AE, Muninarasimaiah S, Raghavan SC, Choudhary B. Acute toxicity analysis of an inhibitor of BCL2, Disarib, in rats. Sci Rep 2021;11:9982. [PMID: 33976278 DOI: 10.1038/s41598-021-89387-x] [Reference Citation Analysis]
5 Arulananda S, Lee EF, Fairlie WD, John T. The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. Expert Rev Anticancer Ther 2021;21:413-24. [PMID: 33238762 DOI: 10.1080/14737140.2021.1856660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cintron-Diaz YL, Acanda de la Rocha AM, Castellanos A, Chambers JM, Fernandez-Lima F. Mapping chemotherapeutic drug distribution in cancer cell spheroids using 2D-TOF-SIMS and LESA-TIMS-MS. Analyst 2020;145:7056-62. [PMID: 32966375 DOI: 10.1039/c9an02245g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lin B, Lu B, Hsieh IY, Liang Z, Sun Z, Yi Y, Lv W, Zhao W, Li J. Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer. Front Pharmacol 2020;11:632. [PMID: 32477122 DOI: 10.3389/fphar.2020.00632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wang J, Zhang Y, Liu X, Wang J, Li B, Liu Y, Wang J. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway. Int J Mol Med 2019;44:1026-38. [PMID: 31524219 DOI: 10.3892/ijmm.2019.4268] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Nayman AH, Siginc H, Zemheri E, Yencilek F, Yildirim A, Telci D. Dual-Inhibition of mTOR and Bcl-2 Enhances the Anti-tumor Effect of Everolimus against Renal Cell Carcinoma In Vitro and In Vivo. J Cancer 2019;10:1466-78. [PMID: 31031856 DOI: 10.7150/jca.29192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
10 Donato S, Santos R, Simões H, Leite V. Novel therapies against aggressive differentiated thyroid carcinomas. International Journal of Endocrine Oncology 2018;5:IJE05. [DOI: 10.2217/ije-2017-0022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen Y, Chen S, Liang H, Yang H, Liu L, Zhou K, Xu L, Liu J, Yun L, Lai B, Song L, Luo H, Peng J, Liu Z, Xiao Y, Chen W, Tang H. Bcl-2 protects TK6 cells against hydroquinone-induced apoptosis through PARP-1 cytoplasm translocation and stabilizing mitochondrial membrane potential: Bcl-2 Protects TK6 Cells Against Hydroquinone-Induced Apoptosis. Environ Mol Mutagen 2018;59:49-59. [DOI: 10.1002/em.22126] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
12 Luo YH, Liang L, He RQ, Wen DY, Deng GF, Yang H, He Y, Ma W, Cai XY, Chen JQ, Chen G. RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients. Oncotarget 2017;8:74139-58. [PMID: 29088774 DOI: 10.18632/oncotarget.18274] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
13 French JD, Bible K, Spitzweg C, Haugen BR, Ryder M. Leveraging the immune system to treat advanced thyroid cancers. Lancet Diabetes Endocrinol 2017;5:469-81. [PMID: 27773653 DOI: 10.1016/S2213-8587(16)30277-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]